Biomarker combination for diagnosing abdominal aortic aneurysm
By utilizing seven differential bacterial genera in the intestinal flora, a biomarker combination for abdominal aortic aneurysms was established, which solved the problem of lack of early diagnostic strategies in the prior art and achieved high levels of abdominal aortic aneurysms. Accurate diagnosis fills the gap in diagnosis and treatment in the prior art.
Patent Information
- Application Number
- CN202410962623.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-18
- Publication Date
- 2024-11-12
AI Technical Summary
The lack of effective drugs and diagnostic methods for limiting the expansion of abdominal aortic aneurysms in the prior art leads to the reliance on imaging surveillance and surgery, and the lack of early diagnostic strategies.
A biomarker combination consists of 7 differential bacterial species (Fusobacterium Fusobacterium, Romboutsia, Clostridium XIVb type Clostridium XIVb, Lactobacillus, Roseburia, Asaccharobacterium, Helicobacterium Helicobacter) , Early diagnosis of abdominal aortic aneurysms is performed through fecal samples and microbiomics techniques.
New early diagnostic strategies are provided, and the combination of biomarkers established through microbiomics technology has significantly improved the diagnostic accuracy of abdominal aortic aneurysms. It uses changes in intestinal flora to identify AAA, which enhances the AAA Clinical diagnostic value.
Smart Images

Figure CN118932053A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the field of medical technology, and in particular to a biomarker combination for diagnosing abdominal aortic aneurysm. Background Art
[0002] Abdominal aortic aneurysm (AAA) is a common aortic disease in clinical practice, and its clinical outcome - rupture, is often catastrophic. Epidemiological surveys show that AAA mainly occurs in elderly patients. Among people over 60-65 years old, its incidence can reach 1.6%-7.2%. The incidence in men is significantly higher than that in women, about 1.9%-18.5% in men and about 0%-4.2% in women. In addition, autopsy results show that 0.5%-3.2% of the deceased have AAA, indicating that a considerable number of AAA patients have no obvious symptoms. The typical clinical manifestation of AAA is abnormal dilation of the infrarenal abdominal aorta, which is characterized by full-thickness, permanent and irreversible dilation. The diagnosis of AAA mainly relies on imaging, such as US, CT, and magnetic resonance imaging. The diagnostic criteria for AAA are relatively unified. It is generally believed that the diagnosis can be made when the diameter of the abdominal aorta after dilation is greater than 3 cm or exceeds 50% of the normal diameter. The danger of AAA is mainly reflected in the sudden rupture of the aneurysm during dilation.
[0003] At present, the treatment of AAA is still relatively simple, mainly relying on imaging monitoring and surgery, and the dividing point is the maximum diameter of AAA. For AAA with a maximum diameter ≥5.0 or 5.5cm, surgical intervention is the first choice. Surgical intervention methods include open and interventional. Considering the high complication rate and mortality rate of open surgery, endovascular repair has gradually replaced open surgery as the first-line treatment for AAA in the past two decades. However, for AAA whose maximum diameter does not meet the intervention standard, close monitoring based on ultrasound is the only feasible and passive treatment strategy. The root cause is the lack of effective drugs that can limit the expansion of AAA. So far, many drug clinical trials at home and abroad have invested a lot in AAA research, but with little success, and new drug research and development directions are urgently needed.
[0004] AAA is essentially the destruction and remodeling of the stability of the abdominal aorta structure, but its accompanying pathological mechanism is very complex. AAA pathological characteristics include arterial wall inflammation and immune cell infiltration, apoptosis and / or phenotypic transformation of smooth muscle cells in the middle layer, activation of matrix metalloproteinases, degradation of extracellular matrix, oxidative stress response and hemodynamic changes. Risk factors for AAA include advanced age, male sex, smoking, atherosclerosis (AS), etc. In 2010, a retrospective cohort study involving 3 million people found that the higher the frequency of fruit, weekly vegetables, nuts, and fish intake, and the lower the frequency of red meat and processed meat intake, the lower the prevalence of AAA. Similarly, in 2013, Stackelberg et al. conducted a prospective cohort study involving 80,426 subjects and showed that consuming 2 servings of fruit per day can reduce the incidence of AAA by 31% and the rupture rate by 39%. The above studies suggest that there is a non-negligible correlation between dietary patterns and AAA, and its mechanism needs to be further explained.
[0005] The intestine is the largest microbial reservoir in the human body, with more than 1,000 species and 1014 orders of magnitude of microorganisms living in it, with a density of up to 10 12 cells / ml. The intestinal microbiota is complex and diverse, of which more than 99% are bacteria. The intestinal flora evolves with the host and becomes an integral part of the human body. The flora acquired at birth develops in parallel with the development of the host and maintains its relative stability and diversity in adulthood until death. The human intestinal flora encodes about 4×10 6 genes, which is 150 times that of the human genome. Therefore, the intestinal flora is also called the second genome of the human body. The research methods of intestinal flora mainly include 16S amplicon and metagenomic sequencing, among which the former is the most commonly used and also the most suitable for exploratory research. The DNA sequence corresponding to the bacterial 16S rRNA exists in the genome of all bacteria. In the 16S rDNA molecule, highly conserved sequences, moderately conserved sequences and highly variable sequences exist at the same time. Therefore, in order to study the intestinal flora, primers can be designed using conservative sequences to amplify 16SrDNA fragments. Then, different bacterial genera are identified by differential classification using variable sequences. The V3-V4 region of 16S rDNA has approximately 450 to 470 nucleotides, which is convenient for sequence analysis.
[0006] In the past decade, a large number of studies have confirmed that intestinal flora disorders are closely related to a variety of cardiovascular diseases, such as coronary heart disease and heart failure. At the same time, many studies have shown that intestinal flora plays a key role in the body's immune and inflammatory response. Intestinal flora may regulate vascular remodeling in various cardiovascular diseases by affecting inflammation, immunity, oxidative stress response, endothelial / smooth muscle cell function, etc. Summary of the invention
[0007] The purpose of the present invention is to provide a biomarker combination for diagnosing abdominal aortic aneurysm, thereby providing a new strategy for the early diagnosis of abdominal aortic aneurysm.
[0008] The technical solution adopted by the present invention to solve its technical problem is: A biomarker combination for diagnosing abdominal aortic aneurysm, the biomarker combination comprising 7 differential bacterial genera: Fusobacterium, Romboutsia, Clostridium XIVb, Lactobacillus, Roseburia, Asaccharobacter, Helicobacter.
[0009] The biomarker combination is derived from the intestinal flora.
[0010] The biomarker combination is used for early diagnosis of abdominal aortic aneurysm.
[0011] Samples for the biomarker panel were collected from stool.
[0012] The beneficial effect of the present invention is that the present invention uses microbiome technology to establish a diagnostic biomarker combination for abdominal aortic aneurysm, providing a new strategy for the early diagnosis of abdominal aortic aneurysm. BRIEF DESCRIPTION OF THE DRAWINGS
[0013] Figure 1 It is the Anosim analysis diagram of AAA group and HC group; A, weighted Anosim analysis; B, unweighted Anosim analysis; the horizontal axis represents the grouping, and the vertical axis represents the rank of Unifrac distance; R>0, which means that the difference between AAA and HC groups is greater than the difference within the groups; P <0.05 indicates that the statistics are significant and more reliable.
[0014] Figure 2 This is the LEfSe difference analysis diagram between the AAA group and the HC group. A, cluster tree; yellow nodes represent bacterial communities with no significant effect in the AAA group and the HC group, and other color nodes represent bacterial communities with significant effect in both groups; B, LDA values of bacterial communities with significant effect between the AAA group and the HC group obtained after LEfSe analysis, and the threshold was set to LDA absolute value > 2.
[0015] Figure 3 This is the ROC analysis diagram of the differential bacterial genus. A is the ROC of each differential bacterial genus, and B is the ROC obtained after multiple screenings and finding the 7 bacterial genera with the largest ROC. DETAILED DESCRIPTION
[0016] The technical solution of the present invention is further described in detail below through specific embodiments.
[0017] In the present invention, unless otherwise specified, the raw materials and equipment used can be purchased from the market or are commonly used in the art. The methods in the following embodiments, unless otherwise specified, are all conventional methods in the art.
[0018] Example: 1. Research subjects: The AAA group of this study included AAA patients aged ≥60 years diagnosed by ultrasound or CT in Peking Union Medical College Hospital. The diagnostic criteria were infrarenal aorta diameter greater than 3 cm or 1.5 times the normal diameter. Exclusion criteria were patients with a history of antibiotics, probiotics and gastrointestinal disease-related drugs within 6 months, a history of abdominal surgery, infectious diseases, food intolerance and inflammatory bowel disease, and changes in dietary structure in a short period of time. In addition, AAA caused by other causes such as inflammatory and infected aneurysms were excluded.
[0019] 2. Sample collection: Collect fresh feces from the subjects in the early morning on an empty stomach and place them in a dedicated feces storage tube, then quickly freeze them in a liquid nitrogen tank and transfer them to the biological sample bank for storage in a -80°C refrigerator. Ask the subjects to empty their urine before collecting feces samples to avoid contamination of the feces.
[0020] 3. Sequencing process: ① Primer design and synthesis 16S rDNA amplification selection region is V3-V4 region, the primers used are 341F and 806R. Primer design: forward primer (5'-3'): CCTACGGGRSGCAGCAG (341F) (SEQID No.1) reverse primer (5'-3'): GGACTACVVGGGTATCTAATC (806R) (SEQ ID No. 2) ②PCR amplification and product purification Using diluted genomic DNA as a template, PCR was performed using the KAPA HiFi Hotstart ReadyMix PCR kit high-fidelity enzyme (Kapa Biosystems, KK2600 / 2601 / 2602) to ensure the accuracy and efficiency of amplification. The PCR products were detected by 2% agarose gel electrophoresis, and the PCR products were recovered by gel excision using the AxyPrep DNA gel recovery kit (Axygen, AP-GX-4). After recovery, the library quality was checked using the Thermo NanoDrop 2000 UV micro-spectrophotometer and 2% agarose gel electrophoresis. After the library quality inspection was qualified, Qubit was used for library quantification, and the corresponding proportions were mixed according to the data volume requirements of each sample.
[0021] ③ Illumina sequencing Illumina Miseq PE250 was used for sequencing. 16S primers 341F and 806R were used to amplify the V3-V4 region, and a 425 bp amplified fragment was obtained. Adapters were added, and the paired-end data of PE250 was obtained by sequencing using the Illumina platform. Longer sequences were obtained by splicing for 16S analysis.
[0022] 4. Analytical methods ① OTU analysis To facilitate downstream species diversity analysis, long reads were clustered into operational taxonomic units (OTUs). Usearch was used to cluster at 97% similarity, and the clustered sequences were filtered for chimeras to obtain OTUs for species classification. Each OTU was considered to represent a species, which was convenient for subsequent analysis.
[0023] ② α and β diversity analysis The α diversity index of the samples was calculated using QIIME software, and the corresponding dilution curve was made. The rank sum test was performed on each index of α diversity, and the α diversity index with significant differences under different conditions was screened by the rank sum test. The β diversity index was calculated using the QIIME software using an iterative algorithm, and the difference was calculated under the weighted species taxonomic abundance information and the unweighted species taxonomic abundance information.
[0024] ③ Analysis of significant differences Linear discriminant analysis Effect Size (LEfSe): LEfSe uses linear discriminant analysis to estimate the size of the difference effect of each component abundance and find out the communities or species that have a significant difference in sample division. This analysis was performed using LEfSeTools. The rank sum test method was used to perform a significant difference analysis to find out the species that have a significant difference in the division between groups.
[0025] 5. Results Analysis Figure 1This is the Anosim analysis chart of the AAA group and the HC group. The horizontal axis represents all samples (Between) and each group, and the vertical axis represents the rank of the unifrac distance. When the rank of the Between group is higher than that of each other group, it indicates that the difference between groups is greater than the difference within the group. R is between (-1, 1), R>0, indicating that the difference between groups is greater than the difference within the group; R<0, indicating that the difference within the group is greater than the difference between groups. The credibility of the statistical analysis is represented by P, and P<0.05 indicates that the statistics are significant.
[0026] Table 1 MRPP intergroup difference analysis was used to evaluate whether the differences in microbial structure between groups were significant. The AAA group and the HC group showed significant differences between the groups under non-weighted conditions.
[0027] * UniFrac analysis uses the evolutionary information between the sequences of each sample to compare whether there are significant differences in microbial communities in environmental samples in a specific evolutionary lineage. UniFrac can be used for the evaluation and analysis of β-diversity, that is, to compare and analyze samples pairwise to obtain the unifrac distance matrix between samples. The calculation method is as follows: First, an evolutionary tree is constructed using OTU representative sequences from different environmental samples. The Unifrac metric measures the difference between two different environmental samples according to the length of the constructed evolutionary branch. The difference is represented by a 0-1 distance value. The distance between the earliest differentiated branches on the evolutionary tree is 1, that is, the difference is the largest. Samples from the same environment will have a greater probability of being concentrated at the same node in the evolutionary tree, that is, the length of the branches between them is short and the similarity is high. If the two communities are exactly the same, then they do not have their own independent evolutionary process, and the UniFrac value is 0; if the two communities are completely separated in the evolutionary tree, that is, they are two completely independent evolutionary processes, then the UniFrac value is 1. From the definition of UniFrac, it can be seen that it only considers whether the sequence appears in the community, but not the abundance of the sequence. If the two communities contain exactly the same species, then the UniFrac value is 0, regardless of whether the abundance of each species is different or the size of the difference. The weighted unifrac method takes the abundance of sequences into consideration on the basis of UniFrac, and it can distinguish the difference in species abundance. In the calculation, weightedunifrac weights each branch according to the proportion of leaf nodes from the two communities to which each branch points. Therefore, unweighted unifrac can detect the existence of changes between samples, while weighted unifrac can further quantitatively detect the variations in different lineages between samples.
[0028] Figure 2is the difference analysis of LEfSe between AAA group and HC group, AAA represents abdominal aortic aneurysm, HC represents healthy control, Figure 2 Results show that the differential microbiota was analyzed by LDA EffectSize (LEfSe analysis): LEfSe uses linear discriminant analysis (LDA) to estimate the effect of each species abundance on the differential effect and find out the communities or species that have a significant difference in the sample division. LEfSe analysis emphasizes statistical significance and biological relevance. A is a cluster tree, and different colors represent different groups. Nodes of different colors represent microbial groups that play an important role in the group represented by the color. Yellow nodes represent microbial groups that do not play an important role in different groups. The species names represented by the English letters in the figure are shown in the legend on the right. B is the LDA score obtained by linear discriminant analysis of the microbial groups with significant effects in different groups. (LDA threshold is 2). The rank sum test method was used to perform a significant difference analysis between AAA and HC to find out the species or otu that have a significant difference in the division between groups. The difference analysis was performed using the wilcox.test function of the stats package in the R (V3.5.1) language.
[0029] After quality control of the original data, the data were de-chimerized and clustered using Usearch software. When clustering in Usearch, the reads were first sorted from large to small according to abundance, and clustered by 97% similarity to obtain OTU (Operational Taxonomic Units), each of which was considered to represent a species. The number of reads matching the OTU for each sample was counted. In order to avoid analysis bias caused by different sample sequencing data sizes, when the sequencing depth was sufficient, the minimum number of sequences matching the OTU was randomly drawn and leveled to perform Alpha diversity analysis. One read was extracted from each OTU as a representative sequence, and the representative sequence was compared with the RDP database. Each OTU was classified into species, and each OTU represented a species. The species abundance table was obtained, and the genus name could be determined.
[0030] In order to explore the diagnostic value of differential bacterial genera, ROC analysis was performed using MetaboAnalyst 3.0. The results are shown in Figure 3. The AUC values of individual differential bacterial genera were all less than 0.7. After trying to integrate 7 differential bacterial genera (black), it was found that their AUC values could reach 0.834, which has a good clinical diagnostic value for AAA (ROC is the "receiver operating characteristic curve", and its main analysis tool is a curve on a two-dimensional plane - the ROC curve. The value of AUC is the size of the area under the ROC curve. The larger the AUC, the better, indicating that the diagnostic value of the test is higher. ①AUC≈1.0: the most ideal inspection index; ②AUC between 0.7-0.9: the test has high accuracy; ③AUC=0.5: the test has no diagnostic value). Among them, the combined biomarkers - 7 differential bacterial genera include: Fusobacterium, Romboutsia, ClostridiumXIVb, Lactobacillus, Roseburia, Asaccharobacter, and Helicobacter.
[0031] The above-described embodiment is only a preferred solution of the present invention and does not limit the present invention in any form. There are other variations and modifications without exceeding the technical solution described in the claims.
Claims
1. A biomarker combination for diagnosing abdominal aortic aneurysm, characterized in that: The biomarker panel includes 7 differential bacterial genera: Fusobacterium, Romboutsia, ClostridiumXIVb, Lactobacillus, Roseburia, Asaccharobacter, Helicobacter.
2. The biomarker combination according to claim 1, characterized in that: The biomarker combination is derived from the intestinal flora.
3. The biomarker combination according to claim 1, characterized in that: The biomarker combination is used for early diagnosis of abdominal aortic aneurysm.
4. The biomarker combination according to claim 1, characterized in that: Samples for the biomarker panel were collected from stool.
